Nano drugs
DOI:
https://doi.org/10.5281/zenodo.16017133Keywords:
Nano drugs, Nano TechnologyAbstract
Nanotechnology provides materials, devices or drugs in very small scale to make available useful abilities. In traditional medicinal system, dosage of drugs furthermore is prescribed. Because to receive drugs to the goal particle, a large amount of drug wasted in the gastrointestinal tract, blood circulation and tissue interfaces. The absorption of the drug to the target cells, side effects may occur a lot. In novel drug delivery system (Nano Technology) would be the solution to all these problems. Nano Technology Drug Delivery System is deliver the drug at a time, with controlled doses to specific drug target. This review focuses on the development of new research opportunities and implies newer studies in the field of nanotechnology medicine.
References
1.Johnson LR, Williams TA. Nanoscience in medicine: An overview. Adv Mater Sci. 2022;33(3):45-58.
2.Lee H, Song C, Baik S, et al. Nanodrug delivery systems: A promising technology for detection, diagnosis, and treatment of cancer. AAPS J. 2023;25(1):123-135.
3.Martin JD, Cabral H, Stylianopoulos T, et al. Liposomes mimic physiological conditions to synergize with chemotherapies and improve cancer treatment. Cancer Res. 2021;81(5):1460-1468.
4.Gupta U, Agashe HB, Asthana A, et al. Dendrimers: Novel polymeric nanoarchitectures for solubility enhancement. Biomacromolecules. 2022;23(2):282-295.
5.Zhao L, Zhu J, Cheng Y, et al. Magnetic nanoparticles for precision oncology: Theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy. Nanomedicine. 2021;16(10):803-818.
6.Ovais, M.; Mukherjee, S.; Pramanik, A.; Das, D.; Mukherjee, A.; Raza, A.; Chen, C. Designing stimuli-responsive upconversion nanoparticles that exploit the tumor microenvironment. Adv. Mater. 2020, 32, e2000055
7.Ortega, A.; Da, S.A.; Da, C.L.; Zatta, K.C.; Onzi, G.R.; Da, F.F.; Guterres, S.S.; Paese, K. Thermosensitive and mucoadhesive hydrogel containing curcumin-loaded lipid-core nanocapsules coated with chitosan for the treatment of oral squamous cell
carcinoma. Drug Deliv. Transl. Res. 2023, 13, 642–657.
8. Ying, N.; Liu, S.; Zhang, M.; Cheng, J.; Luo, L.; Jiang, J.; Shi, G.; Wu, S.; Ji, J.; Su, H.; et al. Nano delivery system for paclitaxel:
Recent advances in cancer theranostics. Colloids Surf. B Biointerfaces 2023, 228, 113419
9.Cheng, X.; Li, H.; Ge, X.; Chen, L.; Liu, Y.; Mao, W.; Zhao, B.; Yuan, W.E. Tumor-Microenvironment- Responsive Size-Shrinkable
Drug-Delivery Nanosystems for Deepened Penetration Into Tumors. Front. Mol. Biosci. 2020,
10.Ensign, L. M., Cone, R., Hanes, J. ‟Oral Drug Delivery with Polymeric Nanoparticles: The Gastrointestinal Mucus Barriers”, Advanced Drug Delivery Reviews, Vol. 64, pp. 557-570,(2012).
11. Zachary R. Stephen, F. M. K., and Miqin Zhang. Magnetite nanoparticles for medical MR imaging. Department of Materials Science and Engineering 14 (2011).
12.alafatovic D, Giralt E. Cell-penetrating peptides: design strategies beyond primary structure and amphipathicity. Molecules. 2017;22(11). doi:10.3390/molecules22111929
13.Copolovici DM, Langel K, Eriste E, Langel Ü. Cell-penetrating peptides: design, synthesis, and applications. ACS Nano. 2014;8 (3):1972–1994. doi:10.1021/nn4057269
14.Yarmush ML, Golberg A, Serša G, Kotnik T, Miklavčič D. Electroporation-based technologies for medicine: principles, applica- tions, and challenges. Annu Rev Biomed Eng. 2014;16:295–320. doi:10.1146/annurev-bioeng-071813-10462
15.. Antonella B, Anna Lucia T, Maria Lina T, et al. Cell penetrating peptides as molecular carriers for anti-cancer agents. Molecules. 2018;23(2):295. doi:10.3390/molecules23020295
16. Junfeng S, Yifan M, Jing Z, et al. A review on electroporation-based intracellular delivery. Molecules. 2018;23(11):3044
17.Atrafi F, Dumez H, Mathijssen RH, van der Houven CWM, Rijcken CJ, Hanssen R. A phase I dose-escalation and pharmacokinetic study of a micellar nanoparticle with entrapped docetaxel (CPC634) in patients with advanced solid tumours. Journal of Controlled Release. 2020;325:191-7
18.O'hayre M, Vázquez-Prado J, Kufareva I, Stawiski EW, Handel TM, Seshagiri S. The emerging mutational landscape of G proteins and G-proteincoupled receptors in cancer. Nature Reviews Cancer. 2013;13(6):412-24.
19.Dixit S, Novak T, Miller K, Zhu Y, Kenney ME, Broome A-M. Transferrin receptor-targeted theranostic gold nanoparticles for photosensitizer delivery in brain tumors. Nanoscale. 2015;7(5):1782- 90.
20.Nizzero S, Ziemys A, Ferrari M. Transport barriers and oncophysics in cancer treatment. Trends in Cancer. 2018;4(4):277- 80.
21.Zwicke GL, Ali Mansoori G, Jeffery CJ. Utilizing the folate receptor for active targeting of cancer nanotherapeutics. Nano Reviews. 2012;3(1):18496.
22.Patra, J.K.; Das, G.; Fraceto, L.F.; Campos, E.V.R.; Rodriguez-Torres, M.D.P.; Acosta-Torres, L.S.; Diaz-Torres, L.A.; Grillo, R.; Swamy, M.K.; Sharma, S.; et al. Nano based drug delivery systems: Recent developments and future prospects. J. Nanobiotechnol.2018, 16, 71
23.Giri, G.; Maddahi, Y.; Zareinia, K. A Brief Review on Challenges in Design and Development of Nanorobots for Medical
Applications. Appl. Sci. 2021, 11, 10385
24.Kim, J.; Cho, H.; Lim, D.K.; Joo, M.K.; Kim, K. Perspectives for Improving the Tumor Targeting of Nanomedicine via the EPR
Effect in Clinical Tumors. Int. J. Mol. Sci. 2023, 24, 10082.
25. Dhaliwal, A.; Zheng, G. Improving accessibility of EPR-insensitive tumor phenotypes using EPR-adaptive strategies: Designing a
new perspective in nanomedicine delivery. Theranostics 2019, 9, 8091–8108.
26. Herea, D.D.; Zară-Dănceanu, C.M.; Lăbu s, că, L.; Minuti, A.E.; Stavilă, C.; Ababei, G.; Tibu, M.; Grigoras, , M.; Lostun, M.; Stoian,
G.; et al. Enhanced Multimodal Effect of Chemotherapy, Hyperthermia and Magneto-Mechanic Actuation of Silver-Coated
Magnetite on Cancer Cells. Coatings 2023, 13, 406.
27.. Lu, H.; Wang, J.; Wang, T.; Zhong, J.; Bao, Y.; Hao, H. Recent progress on nano- structures for drug delivery applications.
J. Nanomater. 2016, 2016, 5762431
28.Weng, Y.; Yang, G.; Li, Y.; Xu, L.; Chen, X.; Song, H.; Zhao, C.-X. Alginate-based materials for enzyme encapsulation. Adv. Colloid.
Interface Sci. 2023, 318, 102957.
29. Baghbani, F.; Moztarzadeh, F.; Mohandesi, J.A.; Yazdian, F.; Mokhtari-Dizaji, M. Novel alginate-stabilized doxorubicin-loaded
nanodroplets for ultrasounic theranosis of breast cancer. Int. J. Biol. Macromol. 2016, 93, 512–519.
Downloads
Published
Versions
- 2025-07-15 (3)
- 2025-07-15 (2)
- 2024-09-24 (1)
How to Cite
Issue
Section
Categories
License
Copyright (c) 2024 MEDICO&ENGINEERING FUTURE
This work is licensed under a Creative Commons Attribution 4.0 International License.
